ROLE OF CT CHEST IN EVALUATION OF PULMONARY MANIFESTATIONS OF COVID-19 RECOVERED CASES

Authors

  • AARTI Department of Radiodiagnosis, Government Medical College and Rajindra Hospital, Patiala, Punjab, India.
  • SARYU GUPTA Department of Radiodiagnosis, Government Medical College and Rajindra Hospital, Patiala, Punjab, India. https://orcid.org/0000-0002-0148-2529
  • RAMINDERPAL SINGH SIBIA Department of Medicine, Government Medical College and Rajindra Hospital, Patiala, Punjab, India.
  • PUNEET GAMBHIR Department of Community Medicine, Government Medical College and Rajindra Hospital, Patiala, Punjab, India.

DOI:

https://doi.org/10.22159/ajpcr.2023.v16i8.47600

Keywords:

Coronavirus disease 2019, Chest computed tomography, Symptomatic-scan interval, Acute respiratory distress syndrome, Pulmonary sequelae

Abstract

Objective: Pulmonary manifestations may be seen in a number of coronavirus disease 2019 (COVID-19)-recovered the evidence on post-COVID pulmonary sequelae is still limited. Herein, we aim to assess the role of computed tomography (CT) chest in the evaluation of pulmonary manifestations of COVID-19 recovered cases.

Methods: We conducted a hospital-based study in the Department of Radiodiagnosis at Government Medical College and Rajindra Hospital Patiala. It included 182 reverse transcriptase-polymerase chain reaction (RT-PCR)-proven COVID-19 patients after they recovered from the disease with at least one negative RT-PCR test and/or clinical recovery. Clinical data and CT findings in the recovery phase were summarized, and the relationship of different clinical parameters with CT severity scores was analyzed.

Results: The mean (±standard deviation [SD]) age of patients was 50.2±14.7 years, and 62.6% of them were males. The mean (±SD) symptomatic-scan interval was 33.05±22.27 days. Pulmonary abnormalities were found in the majority of the cases in the recovery phase, that is, 176 patients accounting for 96.7%, while six patients had normal scans. Bilateral involvement was seen in 169 out of 176 patients. Common CT patterns observed were ground glass opacities (90.34%), reticular pattern (81.82%), interlobular septal thickening (70.45%), linear opacities (90.34% cases), fibrous stripes (78.41% cases), and consolidation (36.93%). The mean (±SD) CT severity score of our study subjects was 16.10±7.95. Patients were also categorized into four groups according to symptomatic scan interval <1 month, 1–2 month, 2–3 month, and >3 months. We found that residual changes were more severe in patients with shorter symptomatic scan interval.

Conclusion: COVID-19 patients demonstrate persistent pulmonary abnormalities even after clinical recovery. Hence, follow-up in patients with moderate and severe disease is strongly recommended.

Downloads

Download data is not yet available.

References

Rahman S, Montero MT, Rowe K, Kirton R, Kunik F Jr. Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: A review of current evidence. Expert Rev Clin Pharmacol 2021;14:601-21. doi: 10.1080/17512433.2021.1902303, PMID 33705239

Liu R, Lei C, Liao X, Shi S, Li J, Hu D, et al. Semi-quantitative analysis for the dynamic chest CT imaging features from onset to recovery in severe and critical COVID-19. Radiol Infect Dis 2020;7:114-22. doi: 10.1016/j.jrid.2020.07.003, PMID 32838008

Parasher A. COVID-19: Current understanding of its pathophysiology, clinical presentation and treatment. Postgrad Med J 2021;97:312-20. doi: 10.1136/postgradmedj-2020-138577, PMID 32978337

Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA 2020;324:782-93. doi: 10.1001/jama.2020.12839, PMID 32648899

Jalaber C, Lapotre T, Morcet-Delattre T, Ribet F, Jouneau S, Lederlin M. Chest CT in COVID-19 pneumonia: A review of current knowledge. Diagn Interv Imaging 2020;101:431-7. doi: 10.1016/j.diii.2020.06.001, PMID 32571748

Hefeda MM. CT chest findings in patients infected with COVID-19: Review of literature. Egypt J Radiol Nucl Med 2020;51:239. doi: 10.1186/s43055-020-00355-3

Fu Z, Tang N, Chen Y, Ma L, Wei Y, Lu Y, et al. CT features of COVID-19 patients with two consecutive negative RT-PCR tests after treatment. Sci Rep 2020;10:11548. doi: 10.1038/s41598-020-68509-x, PMID 32665633

Deng L, Khan A, Zhou W, Dai Y, Chen R, Chen R, et al. Follow-up study of clinical and chest CT scans in confirmed COVID-19 patients. Radiol Infect Dis 2020;7:106-13. doi: 10.1016/j.jrid.2020.07.002, PMID 32838006

Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet 2021;397:220-32. doi: 10.1016/S0140- 6736(20)32656-8, PMID 33428867

Pan F, Yang L, Liang B, Ye T, Li L, Li L, et al. Chest CT patterns from diagnosis to 1 year of follow-up in patients with COVID-19. Radiology 2022;302:709-19. doi: 10.1148/radiol.2021211199, PMID 34609153

Han X, Fan Y, Alwalid O, Zhang X, Jia X, Zheng Y, et al. Fibrotic interstitial lung abnormalities at 1-year follow-up CT after severe COVID-19. Radiology 2021;301:E438-40. doi: 10.1148/ radiol.2021210972, PMID 34313470

Bernheim A, Mei X, Huang M, Yang Y, Fayad ZA, Zhang N, et al. Chest CT findings in coronavirus disease-19 (COVID-19): Relationship to duration of infection. Radiology 2020;295:200463. doi: 10.1148/ radiol.2020200463, PMID 32077789

Wang C, Shi B, Wei C, Ding H, Gu J, Dong J. Initial CT features and dynamic evolution of early-stage patients with COVID-19. Radiol Infect Dis 2020;7:195-203. doi: 10.1016/j.jrid.2020.08.002, PMID 32864406

Kumar I, Prakash A, Ranjan M, Chakrabarti SS, Shukla RC, Verma A. Short-term follow-up HRCT chest of COVID-19 survivors and association with persistent dyspnea. Egypt J Radiol Nucl Med 2021;52:227. doi: 10.1186/s43055-021-00607-w

Liu D, Zhang W, Pan F, Li L, Yang L, Zheng D, et al. The pulmonary sequalae in discharged patients with COVID-19: A short-term observational study. Respir Res 2020;21:125. doi: 10.1186/s12931- 020-01385-1, PMID 32448391

Garg M, Prabhakar N, Bhatia H, Dhooria S, Debi U, Muthu V, et al. CT findings in sequel of COVID-19 pneumonia and its complications. BJR Open 2021;3:20210055. doi: 10.1259/bjro.20210055, PMID 36570781

Brogna B, Bignardi E, Salvatore P, Alberigo M, Brogna C, Megliola A, et al. Unusual presentations of COVID-19 pneumonia on CT scans with spontaneous pneumomediastinum and loculated pneumothorax: A report of two cases and a review of the literature. Heart Lung 2020;49:864-8. doi: 10.1016/j.hrtlng.2020.06.005, PMID 32693960

Frija-Masson J, Debray MP, Gilbert M, Lescure FX, Travert F, Borie R, et al. Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection. Eur Respir J 2020;56:2001754. doi: 10.1183/13993003.01754-2020

Zhao YM, Shang YM, Song WB, Li QQ, Xie H, Xu QF, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalmedicine 2020;25:100463. doi: 10.1016/j.eclinm.2020.100463, PMID 32838236

Lee JH, Yim JJ, Park J. Pulmonary function and chest computed tomography abnormalities 6-12 months after recovery from COVID-19: A systematic review and meta-analysis. Respir Res 2022;23:233. doi: 10.1186/s12931-022-02163-x, PMID 36068582

Darcis G, Bouquegneau A, Maes N, Thys M, Henket M, Labye F, et al. Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: A monocentric prospective observational cohort study. Int J Infect Dis 2021;109:209-16. doi: 10.1016/j.ijid.2021.07.016, PMID 34273510

Vijayakumar B, Tonkin J, Devaraj A, Philip KE, Orton CM, Desai SR, et al. CT lung abnormalities after COVID-19 at 3 months and 1 year after hospital discharge. Radiology 2022;303:444-54. doi: 10.1148/ radiol.2021211746, PMID 34609195

Published

07-08-2023

How to Cite

AARTI, S. GUPTA, R. S. SIBIA, and P. GAMBHIR. “ROLE OF CT CHEST IN EVALUATION OF PULMONARY MANIFESTATIONS OF COVID-19 RECOVERED CASES”. Asian Journal of Pharmaceutical and Clinical Research, vol. 16, no. 8, Aug. 2023, pp. 33-39, doi:10.22159/ajpcr.2023.v16i8.47600.

Issue

Section

Original Article(s)